Pharmaceuticals Global On demand · 24-48h

Global Melatonin, 5-Htp And Serotonin Market Strategic Research Report

Global Melatonin, 5-Htp And Serotonin Market Strategic Resea…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Melatonin, 5-Htp And Serotonin Market
$1.5B2025
6.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Tablets, Capsules, Gummy, Others

By Application: Supermarkets, Health Stores, Drug Stores, Online Pharmacy, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: NBTY, Natrol, Nature Made (Pharmavite), Jamieson, GNC, Vitafusion (Church & Dwight), By-Health, Now Foods, Vicks (Procter & Gamble), OLLY (Unilever), Life Extension, Doctor's Best (Kingdomway), Swanson, Amway

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 115 pages
Market size 2025
$1.5B
Billion USD
Forecast CAGR
6.7%
2025-2032
Forecast 2032
$2.4B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Melatonin, 5-Htp And Serotonin market size is predicted to grow from US$ 1,501 million in 2025 to US$ 2,346 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.

Melatonin, also known as N-acetyl-5-methoxytryptamine, is a hormone produced by the animal pineal gland, which regulates sleep and arousal. Melatonin is also produced in plants, where it is the first line of defense against oxidative stress. Melatonin participates in the regulation of sleep wake cycle, which can improve circadian dysrhythmic sleep wake disorders such as sleep wake disorder and sleep wake phase delay disorder caused by jet lag.

5-HTP produces serotonin, which can be converted into the hormone melatonin. 5-HTP dietary supplements help raise serotonin levels in the brain.

The global top five melatonin, 5-Htp and serotonin manufacturers include Natrol, NBTY, Vicks (Procter & Gamble), GNC, Nature Made (Pharmavite), accounting for more than 20% of the total market share, of which the largest producer is Natrol, with a market share of about 6%. North America is the global largest consumer market for melatonin, 5-Htp and serotonin, with a market share of over 40%. In terms of type, the market share of tablets is over 30%. In the field of application, the market share of health stores has reached more than 35%.

This report presents a comprehensive overview of the global Melatonin, 5-Htp And Serotonin market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Tablets
  • Capsules
  • Gummy
  • Others

Segment by players, this report covers

  • NBTY
  • Natrol
  • Nature Made (Pharmavite)
  • Jamieson
  • GNC
  • Vitafusion (Church & Dwight)
  • By-Health
  • Now Foods
  • Vicks (Procter & Gamble)
  • OLLY (Unilever)
  • Life Extension
  • Doctor's Best (Kingdomway)
  • Swanson
  • Amway

Segment by Application

  • Supermarkets
  • Health Stores
  • Drug Stores
  • Online Pharmacy
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Melatonin, 5-Htp And Serotonin market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Supermarkets, Health Stores, Drug Stores evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Melatonin, 5-Htp And Serotonin Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.5B
2025
Forecast
$2.4B
2032
CAGR
6.7%
2025–2032
Régions
5
global
Key companies
NBTYNatrolNature Made (Pharmavite)JamiesonGNCVitafusion (Church & Dwight)By-HealthNow Foods
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
TabletsCapsulesGummyOthers
By Application
SupermarketsHealth StoresDrug StoresOnline PharmacyOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Tablets
  • 3.1.3 Capsules
  • 3.1.4 Gummy
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Supermarkets
  • 4.1.3 Health Stores
  • 4.1.4 Drug Stores
  • 4.1.5 Online Pharmacy
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 NBTY
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Natrol
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Nature Made (Pharmavite)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Jamieson
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 GNC
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Vitafusion (Church & Dwight)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 By-Health
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Now Foods
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Vicks (Procter & Gamble)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 OLLY (Unilever)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Life Extension
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Doctor's Best (Kingdomway)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Swanson
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Amway
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Melatonin, 5-Htp And Serotonin market?
The global Melatonin, 5-Htp And Serotonin market is estimated at US$ 1.5 billion in 2025 (base year) and is projected to reach US$ 2.35 billion by 2032.
How fast is the Melatonin, 5-Htp And Serotonin market expected to grow?
The market is expected to grow at a CAGR of 6.7% from 2026 to 2032, expanding from US$ 1.5 billion in 2025 to US$ 2.35 billion in 2032, roughly 1.6 times its base-year value.
What does the Melatonin, 5-Htp And Serotonin market cover?
Melatonin, also known as N-acetyl-5-methoxytryptamine, is a hormone produced by the animal pineal gland, which regulates sleep and arousal. Melatonin is also produced in plants, where it is the first line of defense against oxidative stress. Melatonin participates in the regulation of sleep wake cycle, which can improve circadian dysrhythmic sleep wake disorders such as sleep wake disorder and sleep wake phase delay disorder caused by jet lag.
How is the Melatonin, 5-Htp And Serotonin market segmented by type?
By type, the market is segmented into Tablets, Capsules, Gummy and Others.
What are the key applications of Melatonin, 5-Htp And Serotonin?
Key applications covered include Supermarkets, Health Stores, Drug Stores, Online Pharmacy and Others.
Which companies are profiled in the Melatonin, 5-Htp And Serotonin market report?
Key players profiled include NBTY, Natrol, Nature Made (Pharmavite), Jamieson, GNC, Vitafusion (Church & Dwight), By-Health and Now Foods, among 14 companies covered in total.
What geographies does the Melatonin, 5-Htp And Serotonin market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Melatonin, 5-Htp And Serotonin market report?
The report is intended for manufacturers and solution providers, distributors and end users in Supermarkets, Health Stores and Drug Stores, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Melatonin, 5-Htp And Serotonin market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.